ICOSAVAX, INC.

(ICVX)
  Bericht
Verzögert Nasdaq  -  22:00 18.08.2022
6.980 USD   -5.93%
16.08.SEKTOR-UPDATE : Aktien des Gesundheitswesens tendieren kurz vor Handelsschluss am Dienstag tiefer
MT
16.08.SEKTOR-UPDATE : Aktien des Gesundheitswesens heute Nachmittag knapp niedriger
MT
16.08.SEKTOR UPDATE : Gesundheitswesen
MT
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über ICOSAVAX, INC.
16.08.SECTOR UPDATE : Health Care Stocks Edging Lower Near Tuesday Close
16.08.SECTOR UPDATE : Health Care Stocks Narrowly Lower This Afternoon
16.08.SECTOR UPDATE : Health Care
16.08.ICOSAVAX : Corporate Overview
16.08.Icosavax Q2 Net Loss Narrows, Revenue Declines
15.08.ICOSAVAX, INC. Management's Discussion and Analysis of Financial Condition and Results..
15.08.ICOSAVAX : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - F..
15.08.Earnings Flash (ICVX) ICOSAVAX Posts Q2 Loss $-0.57
15.08.Earnings Flash (ICVX) ICOSAVAX Posts Q2 Loss $-0.57
15.08.Icosavax Reports Second Quarter 2022 Financial Results and Provides Corporate Update
15.08.Icosavax, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Jun..
28.07.ICOSAVAX : Corporate Overview
28.07.Icosavax Announces Results from IVX-411 Drug Product Investigation and Outlines Additio..
28.07.Icosavax Announces Results from Ivx-411 Drug Product Investigation and Outlines Additio..
06.07.Icosavax to Participate in the William Blair Biotech Focus Conference
29.06.SECTOR UPDATE : Health Care Stocks Climb Premarket Wednesday
28.06.Icosavax Reports Interim Trial Results for Respiratory Syncytial Virus Vaccine Candidat..
28.06.ICOSAVAX : Announces Positive Topline Interim Phase 1/1b Results for VLP Vaccine Candidate..
28.06.ICOSAVAX, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
28.06.Icosavax Announces Positive Topline Interim Phase 1/1b Results for VLP Vaccine Candidat..
28.06.Icosavax, Inc. Announces Positive Topline Interim Phase 1/1b Results for VLP Vaccine Ca..
24.06.ICOSAVAX, INC.(NASDAQGS : ICVX) dropped from Russell Microcap Growth Index
24.06.ICOSAVAX, INC.(NASDAQGS : ICVX) dropped from Russell 3000E Growth Index
24.06.ICOSAVAX, INC.(NASDAQGS : ICVX) dropped from Russell 3000 Growth Index
24.06.ICOSAVAX, INC.(NASDAQGS : ICVX) dropped from Russell Small Cap Comp Growth Index
24.06.ICOSAVAX, INC.(NASDAQGS : ICVX) dropped from Russell 2000 Growth Index
24.06.ICOSAVAX, INC.(NASDAQGS : ICVX) dropped from Russell 2500 Growth Index
15.06.ICOSAVAX, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
07.06.ICOSAVAX : Corporate Overview
01.06.Icosavax to Participate in the Jefferies Healthcare Conference
23.05.Top Premarket Decliners
16.05.ICOSAVAX, INC. Management's Discussion and Analysis of Financial Condition and Results..
16.05.Earnings Flash (ICVX) ICOSAVAX Posts Q1 Loss $-0.60
16.05.Icosavax Reports First Quarter 2022 Financial Results and Provides Corporate Update
16.05.Icosavax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
25.04.ICOSAVAX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
31.03.Icosavax's Q4 Loss Narrows, Revenue Rises
30.03.ICOSAVAX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
30.03.ICOSAVAX : Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corpor..
30.03.Icosavax, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended Dece..
30.03.Icosavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corpo..
30.03.Earnings Flash (ICVX) ICOSAVAX Reports Q4 Loss $-0.46
25.03.Icosavax Shares Plunge After Interim Data Show Response Below Expectations for COVID-19..
25.03.Top Midday Decliners
25.03.Icosavax Says Interim Data Show Response Below Expectations for COVID-19 Drug Candidate..
25.03.ICOSAVAX : Material Event - Form 8-K
25.03.ICOSAVAX, INC. : Other Events (form 8-K)
25.03.Icosavax Announces Topline Interim Phase 1/2 Results for IVX-411 Against SARS-CoV-2
25.03.Icosavax, Inc. Announces Topline Interim Phase 1/2 Results for IVX-411 Against SARS-CoV..
15.03.UNIVERSITY OF TEXAS AT AUSTIN : New Type of Vaccines Could Help Against More Respiratory I..
09.03.INSIDER SELL : Icosavax
02.03.Icosavax to Participate in the Cowen 42nd Annual Health Care Conference
11.02.ICOSAVAX, INC. : Change in Directors or Principal Officers (form 8-K)
26.01.Certain Common Stock of Icosavax, Inc. are subject to a Lock-Up Agreement Ending on 26-..
26.01.Certain Stock Options of Icosavax, Inc. are subject to a Lock-Up Agreement Ending on 26..
26.01.Certain Restricted Stock Units of Icosavax, Inc. are subject to a Lock-Up Agreement End..
07.01.ICOSAVAX : Provides Corporate Update and Anticipated Milestones for 2022 - Form 8-K
07.01.Icosavax, Inc. Appoints Robin Robinson to Scientific Advisory Board
07.01.Icosavax, Inc. Expands Seattle Headquarters
07.01.Icosavax Provides Corporate Update and Anticipated Milestones for 2022
05.01.ICOSAVAX, INC. : Change in Directors or Principal Officers (form 8-K)
05.01.Icosavax Appoints Dr. John Shiver to Board of Directors
05.01.Icosavax Appoints Dr. John Shiver to Board of Directors
2021ICOSAVAX, INC.(NASDAQGS : ICVX) added to NASDAQ Biotechnology Index
2021ICOSAVAX, INC.(NASDAQGS : ICVX) added to S&P Global BMI Index
2021ICOSAVAX, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financia..
2021ICOSAVAX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
2021ICOSAVAX, INC. Management's Discussion and Analysis of Financial Condition and Results..
2021ICOSAVAX : Reports Third Quarter 2021 Financial Results and Provides Corporate Update - Fo..
2021Earnings Flash (ICVX) ICOSAVAX Posts Q3 Loss $-1.30
2021Icosavax Reports Third Quarter 2021 Financial Results and Provides Corporate Update
2021Icosavax Reports Third Quarter 2021 Financial Results and Provides Corporate Update
2021Icosavax to Participate in Upcoming Investor Conferences
2021Icosavax to Participate in Upcoming Investor Conferences
2021ICOSAVAX, INC.(NASDAQGS : ICVX) added to S&P TMI Index
1  2Weiter